Stock listing

NASDAQ:BMEA Biomea Fusion, Inc. Stock

Home listing (NASDAQ) of Biomea Fusion, Inc.

Follow Biomea Fusion, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BMEA

$0.574 USD +0.044 (+8.4%)

Close on Nov 20, 2026

Past year -42.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.545 – $0.600 USDNov 20, 2026
Volume
1.12M sharesNov 20, 2026
Market cap
$41.75M USDAt the close on Nov 20, 2026 · price × 72.68M shares outstanding
52-week range
$0.450 – $2.237 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.80M USDMedian day 1.48M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Biomea Fusion, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BMEA · Home$0.574 USD+0.044 (+8.4%)1,123,083$0.563$0.600$0.545$0.530Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BMEA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.574+0.044+8.4%$0.563$0.600$0.5451,123,083
$0.530+0.042+8.6%$0.495$0.530$0.4501,043,230
$0.488-0.032-6.2%$0.546$0.555$0.4631,200,006
$0.520-0.062-10.7%$0.583$0.583$0.520512,390
$0.582+0.020+3.5%$0.575$0.600$0.540562,779
$0.563-0.048-7.9%$0.610$0.625$0.563839,006
$0.611+0.064+11.7%$0.569$0.620$0.541694,311
$0.547-0.048-8.1%$0.606$0.615$0.546788,539
$0.595+0.028+5.0%$0.576$0.619$0.548737,128
$0.567-0.021-3.5%$0.578$0.600$0.5401,778,841
$0.587-0.024-4.0%$0.613$0.628$0.5401,437,114
$0.612-0.012-1.9%$0.622$0.675$0.608912,982
$0.624-0.036-5.5%$0.648$0.692$0.624948,512
$0.660+0.020+3.2%$0.636$0.660$0.620792,803
$0.640+0.017+2.7%$0.630$0.649$0.5901,099,866
$0.623-0.025-3.8%$0.633$0.660$0.620677,152
$0.648+0.005+0.8%$0.650$0.660$0.622751,923
$0.642+0.007+1.1%$0.634$0.663$0.6031,312,031
$0.636+0.036+5.9%$0.598$0.636$0.5521,528,167
$0.600+0.015+2.6%$0.590$0.633$0.585958,013
$0.585-0.105-15.2%$0.661$0.700$0.5811,957,330
$0.690-0.045-6.2%$0.740$0.750$0.6843,040,670
$0.736-0.100-12.0%$0.840$0.913$0.7363,551,160
$0.836-0.033-3.8%$0.906$0.906$0.8301,565,580
$0.869+0.032+3.9%$0.839$0.970$0.8003,786,094
$0.836+0.002+0.3%$0.820$0.890$0.8023,135,200
$0.834-0.426-33.8%$0.999$0.999$0.80111,712,700
$1.260-0.100-7.4%$1.435$1.437$1.2308,316,156
$1.360-0.060-4.2%$1.440$1.460$1.3605,368,917
$1.420+0.050+3.6%$1.380$1.450$1.3801,170,623
$1.370+0.050+3.8%$1.320$1.380$1.3001,706,889
$1.320+0.070+5.6%$1.270$1.340$1.250836,126
$1.250-0.050-3.8%$1.280$1.310$1.240797,006
$1.300+0.030+2.4%$1.270$1.310$1.2201,044,351
$1.270-0.030-2.3%$1.300$1.305$1.260844,359
$1.300-0.030-2.3%$1.320$1.360$1.3001,069,849
$1.330+0.070+5.6%$1.290$1.370$1.2601,453,276
$1.260-0.030-2.3%$1.280$1.300$1.2501,556,142
$1.290-0.030-2.3%$1.320$1.365$1.2701,456,718
$1.320-0.170-11.4%$1.490$1.490$1.3033,083,456
$1.490+0.050+3.5%$1.460$1.500$1.3902,185,403
$1.440-0.260-15.3%$1.700$1.720$1.3509,301,263
$1.700-0.010-0.6%$1.710$1.780$1.6602,337,434
$1.710-0.120-6.6%$1.840$1.850$1.6751,785,868
$1.830+0.040+2.2%$1.790$1.930$1.7701,630,910
$1.790+0.050+2.9%$1.780$1.835$1.7201,374,295
$1.740-0.060-3.3%$1.800$1.835$1.7051,596,476
$1.800+0.020+1.1%$1.790$1.815$1.6601,344,127
$1.780+0.040+2.3%$1.715$1.790$1.6601,552,492
$1.740+0.040+2.4%$1.750$1.780$1.7001,481,264
$1.700-0.145-7.9%$1.830$1.840$1.6802,501,258
$1.845-0.085-4.4%$1.940$1.959$1.8152,505,189
$1.930-0.100-4.9%$2.000$2.070$1.8901,853,308
$2.030+0.120+6.3%$1.900$2.050$1.8853,291,010
$1.910-0.025-1.3%$1.930$1.980$1.8401,759,412
$1.935+0.135+7.5%$1.805$1.940$1.7102,136,579
$1.800+0.120+7.1%$1.680$1.870$1.6712,266,537
$1.680-0.050-2.9%$1.720$1.800$1.6801,018,960
$1.730+0.050+3.0%$1.690$1.745$1.6501,168,229
$1.680-0.030-1.8%$1.740$1.850$1.6651,838,255
$1.710-0.020-1.2%$1.755$1.830$1.6503,218,753
$1.730+0.140+8.8%$1.630$1.810$1.5804,457,477
$1.590+0.220+16.1%$1.510$1.770$1.49511,503,100
$1.370+0.010+0.7%$1.370$1.380$1.320572,700
$1.360-0.030-2.2%$1.370$1.380$1.320532,472
Ticker
NASDAQ:BMEA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Biomea Fusion, Inc. news

Biomea Fusion, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
25 in the last 12 months · 129 in all · newest Nov 12, 2026 · oldest 2021
Decks
20 decks · latest Oct 14, 2026

Where Biomea Fusion, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BMEA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BMEABOATSUnited StatesUSD

Valuation

Price/book 5.5× against a median of 3.0×: 7th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$15.85M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
5.5×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.1×
Beta vs S&P 500
1.14

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Biomea Fusion, Inc. · NASDAQ:BMEAUS$41.75MUS$15.85Mn/an/an/a5.5×n/a0.1×1.14
Spero Therapeutics, Inc. · NASDAQ:SPROUS$43.23M−US$63.10Mn/a−1.5×n/a55.4×−71.0%2.0×1.68
Eloxx Pharmaceuticals, Inc. · NASDAQ:ELOXUS$43.15M−US$1.28Mn/an/an/a1.1×n/a0.3×n/a
Corbus Pharmaceuticals Holdings, Inc. · NASDAQ:CRBPUS$42.45M−US$68.98Mn/an/an/a0.5×n/a0.1×1.85
Arecor Therapeutics PLC · LSE:ARECUS$42.37MUS$38.32M48.8×17.1×n/a8.8×38.7%0.0×n/a
OS Therapies Incorporated · AMEX:OSTXUS$42.00MUS$41.57Mn/an/an/an/an/an/a1.70
Advagene Biopharma Co., Ltd. · TPEX:6709US$41.89MUS$32.03Mn/an/an/a3.9×n/a0.0×n/a
Prescient Therapeutics Limited · ASX:PTXUS$41.64MUS$35.80Mn/an/an/a4.4×n/a0.0×n/a
Mereo BioPharma Group plc · NASDAQ:MREOUS$41.52MUS$16.00Mn/a20.0×n/a1.8×n/a0.0×1.34
Elicio Therapeutics, Inc. · NASDAQ:ELTXUS$41.05MUS$19.78Mn/an/an/a2.2×n/a0.5×1.81
MiNK Therapeutics, Inc. · NASDAQ:INKTUS$40.93MUS$33.46Mn/a167×n/an/an/an/a0.81
Median of the othersUS$41.94MUS$25.90M48.8×18.6×3.0×−16.1%0.0×1.69

Forecasts

4 strong buy · 2 buy · 1 sell · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
6.17 USD · Analysts' mean
EPS, year to Dec 2026
-0.62 · 1 analyst

Team and board

Officers

OfficerRole
Michael J.M. HitchcockInterim Chief Executive Officer and Director
Rainer ErdtmannPresident, Chief Operating Officer and Director
Ramses ErdtmannChief Operating Officer and President
Meichiel Jennifer WeissSr. Director of Investor Relations and Corporate Development
Juan Pablo FriasChief Medical Officer and Head of Diabetes

Board

DirectorRole
Bihua ChenDirector
Elizabeth FaustDirector
Eric AguiarLead Independent Director
Michael J.M. HitchcockInterim Chief Executive Officer and Director
Rainer ErdtmannPresident, Chief Operating Officer and Director
Sumita RayDirector

Events

QuarterResultsShare move
Q3 2026Nov 10, 2026 · After close+11.7%
Q2 2026Aug 5, 2026 · After close−0.8%
Q1 2026May 11, 2026 · After close+0.6%
Q4 2025Mar 25, 2026+21.2%
Q3 2025Nov 4, 2025 · After close+6.3%
Q2 2025Aug 5, 2025 · After close+0.6%
Q1 2025May 5, 2025 · After close−16.5%
Q4 2024Mar 31, 2025−13.5%
Q3 2024Oct 29, 2024 · After close−14.3%
Q2 2024Jul 31, 2024 · After close+3.2%
All 20 quarters
QuarterResultsShare move
Q1 2024May 2, 2024 · After close+3.5%
Q4 2023Jan 9, 2024 · After close+2.9%
Q3 2023Oct 30, 2023 · After close−7.6%
Q2 2023Jul 31, 2023 · After close−6.7%
Q1 2023May 2, 2023 · After close+5.8%
Q4 2022Mar 28, 2023 · After close+5.3%
Q3 2022Nov 7, 2022 · After close−6.1%
Q2 2022Aug 1, 2022 · After close+4.3%
Q1 2022May 16, 2022 · Before open+0.5%
Q4 2021Feb 28, 2022 · After close−7.5%

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (October 2026)Technical29 slidesOct 14, 2026
Corporate Update (April 2026)Corporate update27 slidesApr 28, 2026
Investor Presentation (February 2026)Investor deck37 slidesFeb 25, 2026
2026 J.P. Morgan Healthcare ConferenceConference27 slidesJan 14, 2026
Investor Presentation (January 2026)Investor deck51 slidesJan 14, 2026
Corporate Update (June 2025)Corporate update56 slidesJun 17, 2025
American Diabetes Association (ADA) 2025 Scientific SessionsConference20 slidesJune 2025
43rd Annual J.P. Morgan Healthcare Conference (January 2025)Conference39 slidesJan 15, 2025
Technical Presentation (December 2024)Technical25 slidesDec 20, 2024
Technical Presentation (October 2024)Technical26 slidesOct 31, 2024
All 20 decks
DeckKindSlidesDate
JP Morgan Healthcare Conference 2024Conference32 slidesJan 10, 2024
Technical Presentation (December 2023)Technical21 slidesDec 8, 2023
WCIRDC Breakfast Symposium 2023Conference51 slidesDec 7, 2023
Technical Presentation (March 2023)Technical18 slidesMar 28, 2023
JP Morgan Healthcare Conference 2023Conference53 slidesJan 12, 2023
EASD Annual Meeting 2022Conference23 slidesSep 22, 2022
EASD Annual Meeting 2022Conference10 slidesSep 22, 2022
Investor Presentation (January 2022)Investor deck40 slidesJan 12, 2022
Investor Presentation (November 2021)Investor deck34 slidesNov 15, 2021
Investor Presentation (July 2021)Investor deck25 slidesJul 19, 2021

Open Decks

Financings

RaiseDate
Public offering of securities
Cancelled: public offering
Sep 23, 2026
Public offering of common stock and accompanying warrants (or pre-funded warrants in lieu thereof)
Update: about US$25M · US$2.05 a share · 1 warrant at US$2.5 for 36 months · Jefferies +1
Dealers: Jefferies (lead), H.C. Wainwright & Co. (co-lead)
Oct 7, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$17.00 a share on Apr 15, 2021.

Price
US$17.00 a share
Shares offered
9,000,000 shares of common stock
Offering size
US$153 million
Underwriters' option
Up to 1,350,000 more shares
Underwriters
J.P. Morgan, Jefferies, Piper Sandler · In the order on the cover
Shares delivered
On or about Apr 20, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 12, 2021
Filed publiclyMar 26, 2021
Amended twiceNewest Apr 15, 2021
Shares registered with an exchangeApr 14, 2021
Declared effective by the SECApr 15, 2021
Final prospectus, with the priceApr 19, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Apr 19, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue0000000
Cost of revenue1.41M1.75M4.20M1.26M953.0K132.0K
Gross profit-1.41M-1.75M-4.20M-1.26M-953.0K-132.0K
Research and development62.0M118.1M102.5M62.7M28.0M3.67M1.09M
Selling, general and administrative19.3M26.0M23.6M20.9M13.7M1.66M103.0K
Operating income-83.5M-144.1M-126.1M-83.6M-41.7M-5.33M-1.20M
Depreciation and amortization1.41M1.75M1.51M691.0K249.0K8.00K0
EBITDA-82.1M-142.3M-124.6M-82.9M-41.4M-5.32M-1.20M
Interest expense1.81M100.0K00
Income before tax-61.8M-138.4M-117.3M-81.8M-41.6M-5.32M-1.20M
Income tax0000003.00K
Net income-61.8M-138.4M-117.3M-81.8M-41.6M-5.32M-1.20M
Earnings per share, basic-1.18-3.83-3.44-2.80-1.74-0.51-0.20
Earnings per share, diluted-1.18-3.83-3.44-2.80-1.74-0.51-0.20

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents55.8M58.3M176.9M111.9M145.7M61.7M239.0K
Short-term investments01.15M27.8M0
Receivables16.0K
Current assets58.0M68.3M179.2M117.8M176.6M62.2M265.0K
Property, plant and equipment153.0K3.77M5.16M5.84M2.96M81.0K
Total assets58.6M79.9M199.9M129.3M185.7M62.5M265.0K
Accounts payable3.23M12.9M6.85M6.83M1.33M727.0K271.0K
Current liabilities11.1M21.7M22.9M19.1M4.64M1.62M286.0K
Total debt1.59M8.77M10.3M2.29M2.85M259.0K
Total liabilities29.0M28.4M30.7M20.8M6.92M1.62M286.0K
Shareholders' equity29.6M51.6M169.2M108.5M178.8M5.17M-21.0K
Shares outstanding72.3M36.3M35.9M29.6M29.1M12.0M29.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-70.4M-119.9M-96.6M-62.4M-35.4M-4.46M-1.28M
Capital spending0-362.0K-3.37M-1.03M-3.17M-51.0K-51.0K
Free cash flow-70.4M-120.3M-100.0M-63.4M-38.6M-4.51M-1.28M
Cash from investing-362.0K-2.22M27.3M-33.4M-51.0K-51.0K
Cash from financing67.9M1.67M163.8M1.24M153.2M66.0M1.44M
Share buybacks1.24M153.2M
Change in cash-2.47M-118.6M65.0M-33.8M84.4M61.5M161.0K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
8-K · Current reportNov 10, 2026Current reportSEC
8-K · Current reportOct 13, 2026Current reportSEC
424B5 · ProspectusSep 22, 2026Offer documentSEC
8-K · Current reportSep 22, 2026Current reportSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 5, 2026Current reportSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJun 12, 2026Insider tradeSEC
8-K · Current reportJun 11, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 11, 2026Quarterly reportSEC
8-K · Current reportMay 11, 2026ResultsSEC
8-K · Current reportApr 28, 2026Current reportSEC
DEF 14A · Proxy statementApr 27, 2026Meeting noticeSEC
ARS · Annual report to shareholdersApr 27, 2026Annual reportSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
10-K · Annual reportMar 24, 2026Annual reportSEC
8-K · Current reportMar 24, 2026ResultsSEC
8-K · Current reportFeb 25, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 12, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 6, 2026Big-stake noticeSEC
5 · Annual statement of ownershipFeb 6, 2026Insider tradeSEC
8-K · Current reportJan 14, 2026Current reportSEC
S-8 · Registration statement for employee plansJan 6, 2026Offer documentSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeDec 8, 2025Big-stake noticeSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 7, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 4, 2025Quarterly reportSEC
8-K · Current reportNov 4, 2025ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 24, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 10, 2025Big-stake noticeSEC
8-K · Current reportOct 7, 2025Material contractSEC
424B5 · ProspectusOct 7, 2025Offer documentSEC
424B5 · ProspectusOct 6, 2025Offer documentSEC
8-K · Current reportOct 6, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveAug 18, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2025Big-stake noticeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
CORRESP · Letter to the SECAug 13, 2025Other filingsSEC
UPLOAD · Letter from the SECAug 12, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeAug 11, 2025Big-stake noticeSEC
S-3 · Registration statementAug 5, 2025Offer documentSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportAug 5, 2025ResultsSEC
4 · Change in ownershipAug 1, 2025Insider tradeSEC
4 · Change in ownershipJul 24, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 24, 2025Insider tradeSEC
8-K · Current reportJul 24, 2025Management or board changeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 22, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 16, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJun 25, 2025Big-stake noticeSEC
8-K · Current reportJun 20, 2025Material contractSEC
8-K · Current reportJun 18, 2025Material contractSEC
424B5 · ProspectusJun 18, 2025Offer documentSEC
424B5 · ProspectusJun 17, 2025Offer documentSEC
8-K · Current reportJun 17, 2025Current reportSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
8-K · Current reportJun 13, 2025Meeting outcomeSEC
10-Q · Quarterly reportMay 5, 2025Quarterly reportSEC
8-K · Current reportMay 5, 2025ResultsSEC
ARS · Annual report to shareholdersApr 28, 2025Annual reportSEC
DEF 14A · Proxy statementApr 28, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 18, 2025Meeting noticeSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
8-K · Current reportMar 31, 2025ResultsSEC
4 · Change in ownershipMar 28, 2025Insider tradeSEC
8-K · Current reportMar 27, 2025Management or board changeSEC
8-K · Current reportFeb 28, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
8-K · Current reportJan 15, 2025Current reportSEC
S-8 · Registration statement for employee plansJan 6, 2025Offer documentSEC
8-K · Current reportDec 20, 2024Current reportSEC
4 · Change in ownershipDec 2, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
8-K · Current reportOct 31, 2024Current reportSEC
10-Q · Quarterly reportOct 29, 2024Quarterly reportSEC
8-K · Current reportOct 29, 2024ResultsSEC
4 · Change in ownershipOct 1, 2024Insider tradeSEC
8-K · Current reportSep 27, 2024Current reportSEC
10-Q · Quarterly reportJul 31, 2024Quarterly reportSEC
8-K · Current reportJul 31, 2024ResultsSEC
UPLOAD · Letter from the SECJul 18, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedJul 10, 2024Big-stake noticeSEC
CORRESP · Letter to the SECJun 21, 2024Other filingsSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
8-K · Current reportJun 12, 2024Meeting outcomeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
UPLOAD · Letter from the SECJun 12, 2024Other filingsSEC
8-K · Current reportJun 7, 2024Current reportSEC
8-K · Current reportMay 2, 2024ResultsSEC
10-Q · Quarterly reportMay 2, 2024Quarterly reportSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
SC 13G · Big-stake noticeApr 10, 2024Big-stake noticeSEC
8-K · Current reportApr 1, 2024Current reportSEC
8-K · Current reportApr 1, 2024ResultsSEC
10-K · Annual reportMar 28, 2024Annual reportSEC
8-K · Current reportMar 7, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 8, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeJan 29, 2024Big-stake noticeSEC
4 · Change in ownershipJan 18, 2024Insider tradeSEC
4 · Change in ownershipJan 18, 2024Insider tradeSEC
4 · Change in ownershipJan 18, 2024Insider tradeSEC
4 · Change in ownershipJan 18, 2024Insider tradeSEC
8-K · Current reportJan 10, 2024Current reportSEC
S-8 · Registration statement for employee plansJan 5, 2024Offer documentSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipDec 1, 2023Insider tradeSEC
10-Q · Quarterly reportOct 30, 2023Quarterly reportSEC
8-K · Current reportOct 30, 2023ResultsSEC
4 · Change in ownershipSep 1, 2023Insider tradeSEC
3 · Initial statement of ownershipSep 1, 2023Insider tradeSEC
10-Q · Quarterly reportJul 31, 2023Quarterly reportSEC
8-K · Current reportJul 31, 2023ResultsSEC
8-K · Current reportJul 25, 2023Current reportSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
8-K · Current reportJun 15, 2023Meeting outcomeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
144 · Notice of proposed saleMay 19, 2023Other filingsSEC
4 · Change in ownershipMay 17, 2023Insider tradeSEC
4 · Change in ownershipMay 10, 2023Insider tradeSEC
SC 13G · Big-stake noticeMay 10, 2023Big-stake noticeSEC
8-K · Current reportMay 2, 2023Current reportSEC
10-Q · Quarterly reportMay 2, 2023Quarterly reportSEC
8-K · Current reportMay 2, 2023ResultsSEC
ARS · Annual report to shareholdersApr 28, 2023Annual reportSEC
DEF 14A · Proxy statementApr 28, 2023Meeting noticeSEC
144 · Notice of proposed saleApr 27, 2023Other filingsSEC
4 · Change in ownershipApr 26, 2023Insider tradeSEC
144 · Notice of proposed saleApr 20, 2023Other filingsSEC
4/A · Change in ownership, amendedApr 6, 2023Insider tradeSEC
4 · Change in ownershipApr 6, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedApr 3, 2023Big-stake noticeSEC
4 · Change in ownershipApr 3, 2023Insider tradeSEC
8-K · Current reportApr 3, 2023Material contractSEC
424B5 · ProspectusMar 30, 2023Offer documentSEC
424B5 · ProspectusMar 29, 2023Offer documentSEC
8-K · Current reportMar 28, 2023Current reportSEC
10-K · Annual reportMar 28, 2023Annual reportSEC
8-K · Current reportMar 28, 2023ResultsSEC
SC 13G · Big-stake noticeFeb 14, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2023Big-stake noticeSEC
5 · Annual statement of ownershipFeb 10, 2023Insider tradeSEC
4/A · Change in ownership, amendedFeb 10, 2023Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2023Big-stake noticeSEC
8-K · Current reportJan 12, 2023Current reportSEC
4 · Change in ownershipJan 10, 2023Insider tradeSEC
4 · Change in ownershipJan 10, 2023Insider tradeSEC
4 · Change in ownershipJan 10, 2023Insider tradeSEC
S-8 · Registration statement for employee plansJan 4, 2023Offer documentSEC
8-K · Current reportDec 16, 2022Current reportSEC
8-K · Current reportDec 13, 2022Current reportSEC
4 · Change in ownershipDec 2, 2022Insider tradeSEC
8-K · Current reportNov 25, 2022Material contractSEC
424B5 · ProspectusNov 25, 2022Offer documentSEC
4 · Change in ownershipNov 16, 2022Insider tradeSEC
4 · Change in ownershipNov 14, 2022Insider tradeSEC
10-Q · Quarterly reportNov 7, 2022Quarterly reportSEC
8-K · Current reportNov 7, 2022ResultsSEC
8-K · Current reportNov 1, 2022Current reportSEC
EFFECT · Notice that a registration is effectiveOct 25, 2022Other filingsSEC
CORRESP · Letter to the SECOct 20, 2022Other filingsSEC
UPLOAD · Letter from the SECOct 19, 2022Other filingsSEC
8-K · Current reportOct 18, 2022Current reportSEC
S-3 · Registration statementOct 14, 2022Offer documentSEC
8-K · Current reportSep 22, 2022Current reportSEC
8-K · Current reportSep 21, 2022Current reportSEC
8-K · Current reportSep 9, 2022Material contractSEC
8-K · Current reportAug 29, 2022Current reportSEC
4 · Change in ownershipAug 19, 2022Insider tradeSEC
10-Q · Quarterly reportAug 1, 2022Quarterly reportSEC
8-K · Current reportAug 1, 2022ResultsSEC
4 · Change in ownershipJul 25, 2022Insider tradeSEC

This page holds 200 of 292 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Biomea Fusion, Inc.’s releases · as of Oct 29, 2026

Common shares
72,678,080
Fully diluted
72,678,080

Fully diluted

LineSharesAs of
Common shares72,678,080Oct 29, 2026

Share count over time

CountShares
Oct 29, 202672,678,080

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Fidelity8.82M12.1%US$11.7MSep 30, 2026
Vanguard3.22M4.4%US$4.29MSep 30, 2026
Marshall Wace, LLP3.07M4.2%US$4.08MSep 30, 2026
Aisling Capital Management LP2.05M2.8%US$2.74MSep 30, 2026
Mariner, LLC1.57M2.2%US$2.08MSep 30, 2026
Renaissance Technologies1.16M1.6%US$1.55MSep 30, 2026
BlackRock734K1.0%US$977KSep 30, 2026
Susquehanna734K1.0%US$976KSep 30, 2026
Geode Capital731K1.0%US$973KSep 30, 2026
Arrowstreet Capital, Limited Partnership455K0.63%US$605KSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
UBS416K0.57%US$554KSep 30, 2026
Morgan Stanley347K0.48%US$462KSep 30, 2026
MAI Capital Management289K0.40%US$385KSep 30, 2026
ADAR1 Capital Management, LLC268K0.37%US$357KSep 30, 2026
State Street267K0.37%US$355KSep 30, 2026
Griffin Asset Management, Inc.248K0.34%US$330KSep 30, 2026
Gsa Capital Partners LLP244K0.34%US$325KSep 30, 2026
Superstring Capital Management LP226K0.31%US$44,565Sep 30, 2026
LMR Partners LLP200K0.28%US$247KSep 30, 2026
XTX Topco Ltd173K0.24%US$230KSep 30, 2026
Northern Trust126K0.17%US$167KSep 30, 2026
Citadel106K0.15%US$141KSep 30, 2026
Connective Capital Management, LLC103K0.14%US$138KSep 30, 2026
Marex Group Ltd100K0.14%US$133KSep 30, 2026
Birchview Capital, LP93,5000.13%US$124KSep 30, 2026
Graham Capital Management, L.P.92,8920.13%US$124KSep 30, 2026
Bridgeway Capital Management, LLC83,2190.11%US$111KSep 30, 2026
Empowered Funds, LLC83,2190.11%US$111KSep 30, 2026
Goldman Sachs81,8730.11%US$109KSep 30, 2026
Jane Street71,3980.10%US$94,960Sep 30, 2026
LPL Financial LLC57,8650.08%US$76,960Sep 30, 2026
Cantor Fitzgerald, L. P.53,0000.07%US$70,490Sep 30, 2026
Citigroup Inc50,0600.07%US$66,580Sep 30, 2026
Dauntless Investment Group, LLC49,6000.07%US$65,968Sep 30, 2026
Two Sigma45,5260.06%US$60,550Sep 30, 2026
Rathbones Group PLC37,0000.05%US$49,210Sep 30, 2026
Hudson Bay Capital Management LP28,9900.04%US$38,557Sep 30, 2026
Headlands Technologies LLC26,3360.04%US$35,027Sep 30, 2026
Group One Trading LLC24,9580.03%US$33,194Sep 30, 2026
PNC Financial Services Group, Inc.24,0000.03%US$31,920Sep 30, 2026
Tower Research Capital LLC (TRC)18,7150.03%US$24,891Sep 30, 2026
Point72 Asset Management, L.P.16,2240.02%US$21,578Sep 30, 2026
CFS Investment Advisory Services, LLC15,8180.02%US$19,773Sep 30, 2026
BNY15,7710.02%US$20,975Sep 30, 2026
Birch Financial Group, LLC14,0000.02%US$18,620Sep 30, 2026
Millennium12,1850.02%US$16,206Sep 30, 2026
Creative Planning12,0000.02%US$15,960Sep 30, 2026
NewEdge Advisors, LLC12,0000.02%US$15,960Sep 30, 2026
Osaic Holdings, Inc.11,8000.02%US$15,379Sep 30, 2026
HSBC10,9820.02%US$14,606Sep 30, 2026

This page holds 50 of 68 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Fidelity Growth Company Fund2.71M3.7%US$3.74MMay 31, 2026
Vanguard Total Stock Market Index Fund2.12M2.9%US$3.12MJun 30, 2026
Fidelity Growth Company K6 Fund907K1.2%US$1.25MMay 31, 2026
Fidelity Series Growth Company Fund805K1.1%US$1.11MMay 31, 2026
Vanguard Extended Market Index Fund634K0.87%US$932KJun 30, 2026
Select Biotechnology Portfolio453K0.62%US$625KMay 31, 2026
Fidelity Extended Market Index Fund292K0.40%US$402KMay 31, 2026
iShares Micro-Cap ETF231K0.32%US$340KJun 30, 2026
Fidelity Total Market Index Fund109K0.15%US$151KMay 31, 2026
Ultra-Small Company Market Fund84,6000.12%US$124KJun 30, 2026
All 23 holders
HolderSharesOf the companyValueAs of
Fidelity Series Total Market Index Fund82,4130.11%US$114KMay 31, 2026
Goldman Sachs Absolute Return Tracker Fund59,2510.08%US$87,099Jun 30, 2026
Fidelity Nasdaq Composite Index Fund51,9440.07%US$71,683May 31, 2026
Vanguard Balanced Index Fund37,2010.05%US$54,685Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund36,4990.05%US$53,654Jun 30, 2026
Fidelity ZERO Total Market Index Fund28,7930.04%US$33,688Jul 31, 2026
Fidelity ZERO Extended Market Index Fund18,6160.03%US$21,781Jul 31, 2026
1290 VT Micro Cap Portfolio15,5790.02%US$22,901Jun 30, 2026
Fidelity Flex Small Cap Index Fund10,3990.01%US$12,167Jul 31, 2026
VIP Extended Market Index Portfolio4,006<0.01%US$5,889Jun 30, 2026
Total Stock Market Index Trust1,444<0.01%US$2,123Jun 30, 2026
VIP Total Market Index Portfolio1,375<0.01%US$2,021Jun 30, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND383<0.01%US$448Jul 31, 2026

Big stakes

StakeStakeSharesDateFiling
CVI Investments, Inc.9.90%7.85MDec 31, 2025Schedule 13G
Blue Owl Capital Holdings LP5.92%4.45MDec 31, 2025Schedule 13G
Janus Henderson Group PLC5.00%3.75MNov 28, 2025Schedule 13G
Chen Bihua1.53%1.06MOct 22, 2025Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bihua Chen
Other companies: BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); Helix Acquisition Corp. III (Chairperson and CEO, Director · Since at least Jan 22, 2026); BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Aug 11, 2025)
Director · Since at least Jun 11, 2025
Eric Aguiar
Other companies: BridgeBio Pharma, Inc. (Director · Since at least Jun 21, 2024)
Director · Since at least Jun 12, 2024
Franco Valle
Other companies: Eidos Therapeutics Inc (Senior Vice President, Finance · Oct 7, 2020 – Jan 26, 2021 · Past)
Chief Financial Officer · Jul 26, 2021 – Nov 30, 2024 · Past
Elizabeth FaustDirector · Since at least Jun 22, 2022
Juan Pablo FriasChief Medical Officer and Head of Diabetes · Since at least Aug 31, 2023
Julianne AverillDirector · Jul 24, 2025 – Nov 5, 2026 · Past
Meichiel Jennifer WeissSr. Director of Investor Relations and Corporate Development · Since at least May 11, 2026
Michael J.M. HitchcockInterim Chief Executive Officer and Director · Since at least Mar 25, 2025
Rainer ErdtmannSee Remarks, Director · Since at least Dec 29, 2023
Ramses ErdtmannChief Operating Officer and President · Since at least Dec 17, 2024
All 12 people
PersonSeat
Sunny RyanEVP of Finance · Apr 15, 2021 – Apr 15, 2021 · Past
Thomas ButlerChief Executive Officer, Director · Apr 15, 2021 – Mar 25, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about Biomea Fusion, Inc.